The NeuroSakhi initiative aims to close these gaps by strengthening awareness, building patient support networks and improving engagement between healthcare professionals, patients and caregivers across Punjab
The receipt of this permission paves way for the marketing of Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) in India
The formulation is backed by over 80 clinical trials and 200 scientific publications
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
Eculizumab is indicated for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria and atypical Hemolytic Uremic Syndrome
He is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience
Profit Before Tax is Rs. 220 crore, registering a commendable 64% growth
Currently, Venkat is Lead – Market Access, India at Pfizer
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
Subscribe To Our Newsletter & Stay Updated
